Biomarker Assays
Solutions
- Qualified biomarker method list
- Custom reagent generation
- De novo biomarker method development
- Ultrasensitive nanoparticle enabled immunoPCR platform – AmplattoTM
- Multiplex biomarker assays
Success = Access to large number of fit-for-purpose validated methods + Ability to generate quality reagents + Ultra-sensitive technology platform
Biomarker analyses are becoming increasingly important in pre-clinical and clinical trials to understand the biological activity, safety, and efficacy profile of candidate therapeutics.
Somru BioScience has more than 70 methods available to our clients. We continue to add more methods to our list. Very often the development of bioanalytical methods for a novel biomarker is stalled due to lack of quality and specific reagents. Scientists at Somru have significant experience in not only developing robust bioanalytical assays for biomarkers but also have experience in generating quality reagents.
Accurate detection of specific protein biomarkers is crucial for the diagnosis of disease, monitoring drug therapy, and patient screening. Immunoassays have been the method of choice for protein analyte measurements for more than four decades. However, the current immunoassay technologies lack sufficient sensitivity to measure proteins at sub-picomolar level. There is an increasing demand for immunoassays that can detect sub-fM (femtomolar) to aM (attomolar) level of proteins to support early detection of diseases.
Unleashing the power of Amplatto™ technology to achieve attomolar level of analyte detection
Learn.
Engage.
Connect.
Learn | Engage | Connect
Read news, updates, and transforming technologies of drug development
Ultrasensitive bioanalysis and machine
Now Streaming On-Demand While significant advances have been made in..
Read More ...Bringing more affordable medicines
News release Governments of Canada and Prince Edward Island contribute..
Read More ...Biosimilar Development
Biosimilar Development Solutions Off the shelf fully validated assays Proprietary..
Read More ...Mitigating Target Interference Challenges
“Mitigating Target Interference Challenges in Bridging Immunogenicity Assays to Detect..
Read More ...